IBRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 83.40%

Insider Buying (Last 12 Months): $268,516.25

Insider Selling (Last 12 Months): $0.00

ImmunityBio Insider Trading History Chart

ImmunityBio Share Price & Price History

^$5.11

▲ +0.29 (6.02%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

ImmunityBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2023	Michael D. Blaszyk	Director	Buy	71,915	$2.75	$197,766.25	71,915
6/2/2023	John Owen Brennan	Director	Buy	25,000	$2.83	$70,750.00	25,000
10/8/2021	Richard Adcock	CEO	Buy	1,930	$8.81	$17,003.30
8/23/2021	Cheryl Cohen	Director	Sell	14,801	$10.12	$149,786.12	215,418
8/20/2021	Cheryl Cohen	Director	Sell	9,976	$10.00	$99,760.00	215,418
8/17/2021	Cheryl Cohen	Director	Sell	43,398	$10.12	$439,187.76
5/24/2021	Barry J. Simon	Director	Sell	21,223	$16.02	$339,992.46	3,212,517
5/21/2021	Barry J. Simon	Director	Sell	14,990	$16.09	$241,189.10	3,212,517

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for ImmunityBio (NASDAQ:IBRX)

8.58% of ImmunityBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunityBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Simplicity Wealth LLC	10,823	$58K	0.0%	N/A	0.002%
4/23/2024	Wealth Effects LLC	65,500	$0.35M	0.1%	+10.1%	0.010%
4/16/2024	Courier Capital LLC	20,000	$0.11M	0.0%	+33.3%	0.003%
4/15/2024	Brookstone Capital Management	18,715	$100K	0.0%	N/A	0.003%
2/26/2024	Virtu Financial LLC	60,469	$0.30M	0.0%	N/A	0.009%
2/13/2024	Tower Research Capital LLC TRC	9,393	$47K	0.0%	+43.4%	0.001%
2/13/2024	Copperwynd Financial LLC	15,700	$79K	0.0%	N/A	0.002%
2/13/2024	Rafferty Asset Management LLC	739,808	$3.71M	0.0%	N/A	0.111%
2/12/2024	Meridian Management Co.	10,000	$46K	0.0%	N/A	0.001%
2/9/2024	Corient Private Wealth LLC	223,430	$1.12M	0.0%	+28.6%	0.033%
2/8/2024	Vanguard Personalized Indexing Management LLC	16,778	$84K	0.0%	-22.3%	0.003%
2/7/2024	Teacher Retirement System of Texas	30,746	$0.15M	0.0%	-17.2%	0.005%
2/7/2024	E Fund Management Co. Ltd.	39,494	$0.20M	0.0%	N/A	0.006%
2/7/2024	Clearwater Capital Advisors LLC	443,299	$2.23M	0.2%	+12.3%	0.066%
2/6/2024	Charles Schwab Investment Management Inc.	1,142,925	$5.74M	0.0%	+8.9%	0.171%
2/6/2024	Private Advisor Group LLC	10,500	$53K	0.0%	N/A	0.002%
2/6/2024	Sheets Smith Wealth Management	196,679	$0.99M	0.1%	-28.2%	0.029%
2/6/2024	Amalgamated Bank	17,752	$89K	0.0%	+21.9%	0.003%
2/6/2024	Swiss National Bank	263,100	$1.32M	0.0%	-7.6%	0.039%
2/6/2024	New York Life Investment Management LLC	191,221	$0.96M	0.0%	-2.3%	0.029%
2/5/2024	Victory Capital Management Inc.	17,642	$89K	0.0%	+25.8%	0.003%
2/5/2024	Russell Investments Group Ltd.	14,766	$74K	0.0%	+408.3%	0.002%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	28,105	$0.14M	0.0%	+46.6%	0.004%
1/29/2024	Wealth Effects LLC	59,500	$0.30M	0.1%	+11.2%	0.009%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	41,862	$0.21M	0.0%	+290.5%	0.006%
1/24/2024	Stratos Wealth Partners LTD.	34,050	$0.17M	0.0%	N/A	0.005%
1/24/2024	Fishman Jay A Ltd. MI	145,600	$0.73M	0.1%	-10.1%	0.022%
1/24/2024	China Universal Asset Management Co. Ltd.	77,235	$0.39M	0.1%	+560.0%	0.012%
1/17/2024	Courier Capital LLC	15,000	$75K	0.0%	N/A	0.002%
1/16/2024	Carlson Capital Management	17,600	$88K	0.0%	N/A	0.003%
1/12/2024	SG Americas Securities LLC	49,005	$0.25M	0.0%	+45.4%	0.007%
1/5/2024	Exchange Traded Concepts LLC	77,886	$0.39M	0.0%	+34.0%	0.012%
12/18/2023	Vanguard Group Inc.	14,675,687	$24.80M	0.0%	+42.0%	2.198%
11/15/2023	Armistice Capital LLC	3,476,000	$5.87M	0.1%	N/A	0.762%
11/13/2023	Rathbones Group PLC	73,420	$0.12M	0.0%	N/A	0.016%
11/13/2023	WINTON GROUP Ltd	15,438	$26K	0.0%	N/A	0.003%
11/13/2023	Kestra Advisory Services LLC	23,300	$39K	0.0%	-12.7%	0.005%
11/9/2023	Blair William & Co. IL	162,462	$0.28M	0.0%	+200.7%	0.036%
11/8/2023	Vanguard Personalized Indexing Management LLC	21,606	$37K	0.0%	N/A	0.005%
11/8/2023	New York Life Investment Management LLC	195,629	$0.33M	0.0%	-13.6%	0.043%
11/7/2023	Merit Financial Group LLC	43,800	$74K	0.0%	+84.0%	0.010%
11/7/2023	Virtus ETF Advisers LLC	34,461	$58K	0.0%	-9.0%	0.008%
11/7/2023	Barclays PLC	44,373	$75K	0.0%	-26.6%	0.010%
11/3/2023	Liberty One Investment Management LLC	47,578	$80K	0.0%	-5.9%	0.010%
11/1/2023	Stonehage Fleming Financial Services Holdings Ltd	85,000	$0.14M	0.0%	N/A	0.019%
10/30/2023	Aire Advisors LLC	14,768	$25K	0.0%	N/A	0.003%
10/18/2023	Exchange Traded Concepts LLC	58,136	$98K	0.0%	+22.3%	0.013%
10/16/2023	Traynor Capital Management Inc.	14,950	$25K	0.0%	N/A	0.003%
10/16/2023	Wealth Effects LLC	53,500	$90K	0.0%	-24.6%	0.012%
10/13/2023	SG Americas Securities LLC	33,697	$57K	0.0%	N/A	0.007%
9/21/2023	Barclays PLC	60,469	$0.17M	0.0%	+46.5%	0.013%
8/30/2023	Western Wealth Management LLC	20,795	$58K	0.0%	N/A	0.005%
8/9/2023	Sheets Smith Wealth Management	269,129	$0.75M	0.1%	-83.1%	0.062%
8/8/2023	Clearwater Capital Advisors LLC	394,599	$1.10M	0.1%	+24.4%	0.091%
8/7/2023	Principal Financial Group Inc.	74,054	$0.21M	0.0%	+14.3%	0.017%
8/7/2023	New York Life Investment Management LLC	226,447	$0.63M	0.0%	-13.7%	0.052%
8/4/2023	Ascent Wealth Partners LLC	10,000	$28K	0.0%	N/A	0.002%
8/4/2023	American International Group Inc.	53,064	$0.15M	0.0%	+34.3%	0.012%
8/4/2023	Liberty One Investment Management LLC	50,587	$0.14M	0.0%	+63.8%	0.012%
7/20/2023	Exchange Traded Concepts LLC	47,540	$0.13M	0.0%	N/A	0.011%
7/19/2023	Grimes & Company Inc.	10,000	$28K	0.0%	N/A	0.002%
7/18/2023	Wealth Effects LLC	71,000	$0.20M	0.1%	+149.1%	0.016%
7/11/2023	Bard Financial Services Inc.	19,250	$54K	0.0%	N/A	0.004%
6/14/2023	State Board of Administration of Florida Retirement System	22,717	$41K	0.0%	-42.5%	0.005%
5/26/2023	Sheets Smith Wealth Management	1,590,398	$2.90M	0.4%	+3.0%	0.365%
5/15/2023	Sheets Smith Wealth Management	2	$2.90M	0.4%	-100.0%	0.000%
5/12/2023	Inceptionr LLC	18,302	$33K	0.0%	N/A	0.004%
5/11/2023	Meitav Investment House Ltd.	43,429	$0.12M	0.0%	N/A	0.010%
5/10/2023	Clearwater Capital Advisors LLC	317,151	$0.58M	0.1%	+70.6%	0.073%
5/10/2023	Credit Suisse AG	889,699	$1.62M	0.0%	+29.0%	0.204%
5/10/2023	Pictet Asset Management SA	2,421,900	$4.41M	0.0%	+186.2%	0.556%
5/9/2023	Fishman Jay A Ltd. MI	112,000	$0.20M	0.0%	+387.0%	0.026%
5/9/2023	Y Intercept Hong Kong Ltd	39,242	$71K	0.0%	N/A	0.009%
5/8/2023	New York Life Investment Management LLC	262,454	$0.48M	0.0%	N/A	0.060%
5/8/2023	Federated Hermes Inc.	22,007	$40K	0.0%	N/A	0.005%
5/5/2023	Pinnacle Associates Ltd.	107,775	$0.20M	0.0%	N/A	0.025%
5/4/2023	Pinnacle Wealth Management Advisory Group LLC	102,740	$0.19M	0.0%	N/A	0.024%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	26,774	$49K	0.0%	-48.0%	0.006%
5/3/2023	Integrated Wealth Concepts LLC	18,408	$34K	0.0%	N/A	0.004%
4/28/2023	SG Americas Securities LLC	51,013	$93K	0.0%	+193.2%	0.012%
4/24/2023	Merit Financial Group LLC	23,800	$43K	0.0%	N/A	0.005%
4/21/2023	Winning Points Advisors LLC	251,186	$0.46M	0.5%	+3.5%	0.058%
4/18/2023	ETF Managers Group LLC	163,948	$0.30M	0.0%	+64.3%	0.038%
3/23/2023	ETF Managers Group LLC	99,801	$0.51M	0.0%	-15.5%	0.023%
3/8/2023	Sheets Smith Wealth Management	1,544,048	$7.83M	1.2%	+642.6%	0.354%
2/13/2023	Callan Capital LLC	2,980,044	$15.11M	1.8%	N/A	0.744%
2/13/2023	Martingale Asset Management L P	21,166	$0.11M	0.0%	+14.8%	0.005%
2/10/2023	Winning Points Advisors LLC	242,586	$1.23M	1.6%	-3.6%	0.061%
2/10/2023	AXQ Capital LP	16,407	$83K	0.1%	N/A	0.004%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	51,443	$0.26M	0.0%	-12.3%	0.013%
2/9/2023	Principal Financial Group Inc.	68,972	$0.35M	0.0%	+20.6%	0.017%
2/9/2023	Citigroup Inc.	212,605	$1.08M	0.0%	-43.1%	0.053%
2/8/2023	UBS Group AG	368,603	$1.87M	0.0%	+218.0%	0.092%
2/8/2023	Cambridge Investment Research Advisors Inc.	11,950	$61K	0.0%	N/A	0.003%
2/8/2023	Swiss National Bank	290,000	$1.47M	0.0%	+3.2%	0.072%
2/7/2023	State Board of Administration of Florida Retirement System	39,489	$0.20M	0.0%	+76.6%	0.010%
2/6/2023	Private Wealth Group LLC	22,195	$0.11M	0.2%	N/A	0.006%
2/2/2023	SG Americas Securities LLC	17,400	$88K	0.0%	-82.2%	0.004%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	19,173	$97K	0.0%	+39.1%	0.005%
1/25/2023	Mayflower Financial Advisors LLC	16,510	$84K	0.0%	N/A	0.004%

Data available starting January 2016

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in discovering, developing, and commercializing next-generation immuno- and cellular therapies for cancer and infectious diseases in the United States and Europe. The company offers immunotherapy and cell therapy platforms, including antibody cytokine fusion protein N-803, vaccine delivery technologies, and natural killer cell therapies. Its lead biologic commercial product candidate is Anktiva, an IL-15 superagonist antibody-cytokine fusion protein for the treatment of bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ with or without Ta or T1 disease. The company also develops other therapeutic agents for the treatment of liquid and solid tumors, including bladder, lung, colorectal, and ovarian cancers, as well as glioblastoma multiforme, acute myeloid leukemia, and human immunodeficiency virus. It has collaboration agreements with National Cancer Institute and Amyris, Inc.; and license agreements with LadRx Corporation, GlobeImmune, Inc., Access to Advanced Health Institute, 3M Innovative Properties Company, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., and Viracta Therapeutics, Inc. The company is based in San Diego, California.

Today's Range

Now: $5.11

$4.82

$5.18

50 Day Range

MA: $5.20

$3.50

$6.17

52 Week Range

Now: $5.11

$1.25

$6.93

Volume

8,384,593 shs

Average Volume

4,482,548 shs

Market Capitalization

$3.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of ImmunityBio?: ImmunityBio's top insider shareholders include:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More about top insider investors at ImmunityBio.
Who are the major institutional investors of ImmunityBio?: ImmunityBio's top institutional shareholders include:
Wealth Effects LLC — 0.01%
Courier Capital LLC — 0.00%
Brookstone Capital Management — 0.00%
Simplicity Wealth LLC — 0.00%
Learn More about top institutional investors of ImmunityBio stock.
Which institutional investors are buying ImmunityBio stock?: During the previous quarter, IBRX stock was purchased by institutional investors including:
Brookstone Capital Management
Simplicity Wealth LLC
Wealth Effects LLC
Courier Capital LLC
Within the last year, these company insiders have bought ImmunityBio stock:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More investors buying ImmunityBio stock.